Introduce a new highly-demanded noninvasive diagnostic solution for endometriosis patients
The diagnostic test for endometriosis
EndoSearch® will be the first noninvasive diagnostic test for endometriosis.
It will shed light on the presence or absence of endometriosis and allow patient management accordingly. It is a real breakthrough innovation as compared to the current gold standard laparoscopy, which is an invasive surgical procedure with an average delay of 9 years between disease onset and its diagnosis.
Introduce a new highly-demanded noninvasive diagnostic solution for endometriosis patients
Improve patient quality of life
Improve medical practice
Address a major medical need
Offer an easy access to millions of patients
Support for international harmonization of endometriosis diagnosis
EndoSearch® will help physicians in their daily practice, to confirm a suspicion of endometriosis very quickly and easily. It will make a real difference for the physician who can effectively manage patient-care accordingly to the test result.
Endometriosis is a chronic and debilitating condition strongly affecting the quality of life of millions of patients. Lack of a non-invasive diagnostic test contributes to the long delay between onset of symptoms and diagnosis of endometriosis. EndoSearch® provides an easy and noninvasive accurate diagnostic test and replaces the surgery which is expensive and can lead to adverse events.
With EndoSearch® diagnostic test, all symptomatic women who have pelvic pain and/or subfertility could be screened for endometriosis and according to EndoSearch® results efficiently treated, preventing endometriosis progression and damages to other organs but also increasing IVF success rates. EndoSearch® impact on patients will be substantial and will benefit to millions of women.
We are convinced that EndoSearch® will contribute to significantly reduce these endometriosis-associated costs by reducing the number of prescriptions of unsuitable treatments and by limiting the number of surgeries in addition to improve women quality of life with a noninvasive and early diagnostic test.
15 prestigious clinical centres all around the world mainly European (10) and American (4). All selected surgeons are KOLs and experts in endometriosis.
They have access to state of the art facilities and involved in several clinical studies. 1000 patients will be recruited to participate to this study
This project has received founding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 767720.
Fill out the form below if you want to learn more about our company, our products and services, or to discuss a future collaboration. We will be in touch with you shortly